Psychiatry Associates of Kansas City

Psychiatry Associates of Kansas City, located in Leawood, Kansas, offers both Spravato (esketamine) and ketamine for adults with major depressive disorder and treatment-resistant depression. As one of the area's largest psychiatry practices, this privately owned, single-specialty group is committed to bringing life-changing treatments to its patients.

Spravato is an FDA-approved CIII nasal spray for depression that has not responded to standard medications. It sits alongside the practice's other advanced interventional option, TMS therapy, an FDA-approved procedure using magnetic pulses to treat major depression.

The practice also provides medication management, psychiatry, therapy, and diagnostic testing to identify underlying contributors and guide personalized care. On-site pharmacy and lab services are coming soon to support comprehensive treatment.